Clinical Trial Update: Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating patient preference for oral versus intravenous vinorelbine in metastatic non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Non-small Cell Lung Cancer Metastatic | Phase 4 | Status: COMPLETED